Pharma-Bio Serv, Inc. PBSV
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 251.60K | 61.50K | -76.10K | -100.50K | -84.30K |
| Total Depreciation and Amortization | 130.70K | 175.30K | 222.50K | 229.10K | 216.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.60K | 5.20K | 42.90K | -2.50K | -116.50K |
| Change in Net Operating Assets | -832.70K | -481.20K | -364.80K | -341.10K | -431.90K |
| Cash from Operations | -414.80K | -239.20K | -175.50K | -214.90K | -416.20K |
| Capital Expenditure | -6.50K | -7.10K | -9.10K | -6.70K | -163.30K |
| Sale of Property, Plant, and Equipment | 7.00K | 7.00K | 7.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -303.80K | 1.65M | 314.10K | -1.46M | -275.00K |
| Cash from Investing | -303.40K | 1.65M | 312.00K | -1.47M | -438.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -11.60K | -16.60K | -33.10K | -31.40K | -22.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.72M | -1.72M | -1.72M | -1.72M | -1.72M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.73M | -1.73M | -1.75M | -1.75M | -1.74M |
| Foreign Exchange rate Adjustments | 8.10K | 20.20K | 73.10K | 44.50K | 34.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.44M | -301.50K | -1.54M | -3.39M | -2.56M |